Jaguar Health (JAGX) Minority Interest (2021 - 2026)
Jaguar Health's (JAGX) quarterly Minority Interest came in at -$1.6 million in Q1 2026, down 65.34% year-on-year from -$4.5 million in Q1 2025, and down 12.51% on a QoQ basis from -$1.4 million in Q4 2025.
Jaguar Health (JAGX) Minority Interest (2021 - 2026) Analysis & Trends
Jaguar Health (JAGX) has 6 years of Minority Interest data on file, last reported at -$1.6 million in Q1 2026.
- On a quarterly basis, Minority Interest fell 65.34% year-over-year to -$1.6 million in Q1 2026; TTM through Mar 2026 was -$1.6 million, a 65.34% decrease from a year earlier, with the FY2025 full-year figure at -$1.4 million, down 76.86% from the prior year.
- Minority Interest for Q1 2026 stood at -$1.6 million, down from -$1.4 million in the prior quarter.
- Over the last five years, Minority Interest for JAGX reached as high as $310000.0 in Q1 2023 and fell as low as -$1.6 million in Q1 2026.
- Historically, Minority Interest has averaged -$430705.9 across 5 years, with a median of -$180000.0 in 2024.
- Across the five-year window, Minority Interest surged 384.38% in 2023 and plunged 1135.94% in 2024, its largest moves.
- Year by year, Minority Interest stood at $242000.0 in 2022, then slumped by 126.45% to -$64000.0 in 2023, then plunged by 1135.94% to -$791000.0 in 2024, then tumbled by 76.86% to -$1.4 million in 2025, then retreated by 12.51% to -$1.6 million in 2026.
- Per Business Quant data, the three most recent Minority Interest figures were -$1.6 million in Q1 2026, -$1.4 million in Q4 2025, and -$1.3 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Nanobiotix | 1,782.24 Bn | 1,782.18 Bn | - |
| 2 | Akari Therapeutics | 1,009.43 Bn | 1,009.43 Bn | - |
| 3 | BeOne Medicines | 473.46 Bn | 468.66 Bn | 1.35 Bn |
| 4 | Vertex Pharmaceuticals | 123.84 Bn | 116.59 Bn | 2.59 Bn |
| 5 | Regeneron Pharmaceuticals | 71.69 Bn | 62.94 Bn | 3.31 Bn |
| 6 | Belite Bio | 62.15 Bn | 62.15 Bn | - |
| 7 | Argenx Se | 54.74 Bn | 49.55 Bn | 1.41 Bn |
| 8 | Alnylam Pharmaceuticals | 38.08 Bn | 35.07 Bn | 959.66 Mn |
| 9 | Revolution Medicines | 36.07 Bn | 36.07 Bn | - |
| 10 | Jaguar Health | 520,945.88 | -9.54 Mn | 19.11 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.57 Mn |
| Dec 31, 2025 | -1.40 Mn |
| Sep 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.11 Mn |
| Mar 31, 2025 | -952,000.00 |
| Dec 31, 2024 | -791,000.00 |
| Sep 30, 2024 | -514,000.00 |
| Jun 30, 2024 | -328,000.00 |
| Mar 31, 2024 | -180,000.00 |
| Dec 31, 2023 | -64,000.00 |
| Sep 30, 2023 | 56,000.00 |
| Jun 30, 2023 | 191,000.00 |
| Mar 31, 2023 | 310,000.00 |
| Dec 31, 2022 | 242,000.00 |
| Sep 30, 2022 | -48,000.00 |
| Jun 30, 2022 | 41,000.00 |
| Mar 31, 2022 | 64,000.00 |
| Dec 31, 2021 | 242,000.00 |